Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSCAR: Olmesartan +/- Hydrochlorothiazide in Mild to Moderate Essential Hypertension
NCT00139698Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of olmesartan in essential hypertension, sponsored by Pfizer. Started Sep 2005; status: completed.
02
Drugs
olmesartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00139698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139698.